Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...

I got on a GLP-1 drug 16 months ago at the urging of my doctor. Not only did it help me with food and weight, it also turned ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

Which biotechs are most likely to be acquired near-term? We asked Seeking Alpha analysts Edmund Ingham and Terry Chrisomalis for their thoughts on the topic. Read more here.

"If we start seeing lots of cases outside of agricultural workers, we should be really concerned." -- James Lawler, MD, MPH, ...

As the sale of weight loss drugs skyrocket around the country, Illinois’ attorney general is saying buyer beware.

Food manufacturers are trying to whip themselves up a forkful of the slimming trend — but nutrition experts aren't giving ...

A medical spa in Lincoln Park could be the perfect getaway for those looking for nonsurgical aesthetic treatments. Shot Bar ...

GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight ...

Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.